Prognostic value of neutrophil-to-lymphocyte ratio and other inflammatory markers in patients with high-risk soft tissue sarcomas

• Published in: Clinical & translational oncology Vol. 22; no. 10; pp. 1849 - 1856
• Main Authors: Viñal, D., Martinez, D., Garcia-Cuesta, J. A., Gutierrez-Sainz, L., Martinez-Recio, S., Villamayor, J., Martinez-Marin, V., Gallego, A., Ortiz-Cruz, E., Mendiola, M., Pozo-Kreilinger, J. J., Berjon, A., Belinchon, B., Bernabeu, D., Espinosa, E., Feliu, J., Redondo, A.
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.10.2020
• Subjects: Medicine; Medicine & Public Health; Oncology; Research Article; Neutrophil-to-lymphocyte ratio; Chemotherapy; Soft tissue sarcomas

Background Soft tissue sarcomas (STS) have a high risk of relapse in spite of the use of (neo)adjuvant chemotherapy. In this context, looking for new prognostic biomarkers is an interesting field of research. Our aim is to analyze the prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and oth...